18F-Fluciclovine PET/CT in Multiple Myeloma

Clinical trial NCT06103838 · RECRUITING

Trial details

NCT number: NCT06103838
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Newly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)

Start date: 2024-03-25
Primary completion: 2027-12-06
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.